ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ
Comorbidity degrades the quality of life, leads to social exclusion, increased mortality The aim of this study was to investigate the efficacy and tolerability of the drug Afobazol in comorbidity patients of therapeutic profile. 19 patients of therapeutic profile with anxiety disorders (5 males and...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2015-02-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/375 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839572900271620096 |
|---|---|
| author | А. М. Шутов Е. В. Ефремова А. А. Страхов |
| author_facet | А. М. Шутов Е. В. Ефремова А. А. Страхов |
| author_sort | А. М. Шутов |
| collection | DOAJ |
| description | Comorbidity degrades the quality of life, leads to social exclusion, increased mortality The aim of this study was to investigate the efficacy and tolerability of the drug Afobazol in comorbidity patients of therapeutic profile. 19 patients of therapeutic profile with anxiety disorders (5 males and 14 females, mean age was 49,4 ± 16,3 years) were studied during 6 weeks. Comorbidity, efficacy and tolerability of Afobazol were estimated. All patients completed the course. Effective average daily dose was 50 mg (30 to 60 mg/day). There were a reduction of anxiety disorders, improvement the quality of life and cognitive function after treatment of Afobazol There was acceptable compliance to treatment of Afobazol. Afobazole was well- tolerated by patients.tolerability Afobazol comorbid patients. |
| format | Article |
| id | doaj-art-f0cd481010ca486d91d28e3b11b6e5fe |
| institution | Matheson Library |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| publishDate | 2015-02-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj-art-f0cd481010ca486d91d28e3b11b6e5fe2025-08-04T14:09:44ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642015-02-0101707510.20514/2226-6704-2015-0-1-70-75388ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИА. М. Шутов0Е. В. Ефремова1А. А. Страхов2ФГБОУ ВПО «Ульяновский государственный университет», кафедра терапии и профессиональных болезней, г. УльяновскФГБОУ ВПО «Ульяновский государственный университет», кафедра терапии и профессиональных болезней, г. УльяновскФГБОУ ВПО «Ульяновский государственный университет», кафедра терапии и профессиональных болезней, г. УльяновскComorbidity degrades the quality of life, leads to social exclusion, increased mortality The aim of this study was to investigate the efficacy and tolerability of the drug Afobazol in comorbidity patients of therapeutic profile. 19 patients of therapeutic profile with anxiety disorders (5 males and 14 females, mean age was 49,4 ± 16,3 years) were studied during 6 weeks. Comorbidity, efficacy and tolerability of Afobazol were estimated. All patients completed the course. Effective average daily dose was 50 mg (30 to 60 mg/day). There were a reduction of anxiety disorders, improvement the quality of life and cognitive function after treatment of Afobazol There was acceptable compliance to treatment of Afobazol. Afobazole was well- tolerated by patients.tolerability Afobazol comorbid patients.https://www.medarhive.ru/jour/article/view/375comorbidityanxiety disordersafobazol. |
| spellingShingle | А. М. Шутов Е. В. Ефремова А. А. Страхов ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ Архивъ внутренней медицины comorbidity anxiety disorders afobazol. |
| title | ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ |
| title_full | ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ |
| title_fullStr | ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ |
| title_full_unstemmed | ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ |
| title_short | ОСОБЕННОСТИ ТЕРАПИИ ТРЕВОЖНЫХ РАССТРОЙСТВ У БОЛЬНЫХ В УСЛОВИЯХ КОМОРБИДНОСТИ |
| title_sort | особенности терапии тревожных расстройств у больных в условиях коморбидности |
| topic | comorbidity anxiety disorders afobazol. |
| url | https://www.medarhive.ru/jour/article/view/375 |
| work_keys_str_mv | AT amšutov osobennostiterapiitrevožnyhrasstrojstvubolʹnyhvusloviâhkomorbidnosti AT evefremova osobennostiterapiitrevožnyhrasstrojstvubolʹnyhvusloviâhkomorbidnosti AT aastrahov osobennostiterapiitrevožnyhrasstrojstvubolʹnyhvusloviâhkomorbidnosti |